CY1106443T1 - 17β-αμινο και υδροξυλαμινο -11β- αρυλστepοειδη και παραγωγα αυτων που εχουν αγωνιστη ή ανταγωνιστη ορμονικες ιδιοτητες - Google Patents

17β-αμινο και υδροξυλαμινο -11β- αρυλστepοειδη και παραγωγα αυτων που εχουν αγωνιστη ή ανταγωνιστη ορμονικες ιδιοτητες

Info

Publication number
CY1106443T1
CY1106443T1 CY20061101454T CY061101454T CY1106443T1 CY 1106443 T1 CY1106443 T1 CY 1106443T1 CY 20061101454 T CY20061101454 T CY 20061101454T CY 061101454 T CY061101454 T CY 061101454T CY 1106443 T1 CY1106443 T1 CY 1106443T1
Authority
CY
Cyprus
Prior art keywords
arylstepoides
hydroxylamino
antagonist
derivatives
amino
Prior art date
Application number
CY20061101454T
Other languages
English (en)
Inventor
C. Edgar Cook
John A. Kepler
Gary S. Bartley
Rupa S. Shetty
Original Assignee
Research Triangle Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Triangle Institute filed Critical Research Triangle Institute
Publication of CY1106443T1 publication Critical patent/CY1106443T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Abstract

Η εφεύρεση κατευθύνεται σε μια νέα κατηγορία στεροειδών τα οποία δεικνύουν ισχυρή αντιπροεμμηνοροϊκή δραστικότητα.
CY20061101454T 1998-05-29 2006-10-12 17β-αμινο και υδροξυλαμινο -11β- αρυλστepοειδη και παραγωγα αυτων που εχουν αγωνιστη ή ανταγωνιστη ορμονικες ιδιοτητες CY1106443T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/086,560 US6262042B1 (en) 1998-05-29 1998-05-29 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
PCT/US1999/010480 WO1999062928A1 (en) 1998-05-29 1999-05-28 17β-AMINO AND HYDROXYLAMINO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES

Publications (1)

Publication Number Publication Date
CY1106443T1 true CY1106443T1 (el) 2011-10-12

Family

ID=22199388

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101454T CY1106443T1 (el) 1998-05-29 2006-10-12 17β-αμινο και υδροξυλαμινο -11β- αρυλστepοειδη και παραγωγα αυτων που εχουν αγωνιστη ή ανταγωνιστη ορμονικες ιδιοτητες

Country Status (25)

Country Link
US (3) US6262042B1 (el)
EP (1) EP1082337B1 (el)
JP (1) JP4545929B2 (el)
KR (1) KR100611289B1 (el)
CN (1) CN100357311C (el)
AT (1) ATE333462T1 (el)
AU (1) AU753382B2 (el)
BR (1) BR9910794A (el)
CA (1) CA2333669C (el)
CY (1) CY1106443T1 (el)
CZ (1) CZ300313B6 (el)
DE (1) DE69932432T8 (el)
DK (1) DK1082337T3 (el)
ES (1) ES2270596T3 (el)
HK (1) HK1035196A1 (el)
HU (1) HU228770B1 (el)
ID (1) ID26885A (el)
IL (1) IL139861A (el)
NO (1) NO317988B1 (el)
NZ (1) NZ507985A (el)
PL (1) PL198055B1 (el)
PT (1) PT1082337E (el)
RU (1) RU2238943C2 (el)
SK (1) SK285748B6 (el)
WO (1) WO1999062928A1 (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262042B1 (en) * 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
ES2190373B1 (es) * 2001-12-07 2004-10-16 J. URIACH & CIA, S.A. Uso del acido 2-hidroxi- o 2-acetiloxi-4-trifluorometilbenzoico como agente para el tratamiento y prevencion del deterioro cognitivo ligero.
CN100439361C (zh) 2003-03-07 2008-12-03 先灵公司 取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
EP1601669B1 (en) 2003-03-07 2008-12-24 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US8097606B2 (en) * 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
US20070249573A1 (en) * 2006-04-13 2007-10-25 Gerd Schubert 17alpha-substituted 4-(3-oxoestra-4,9-dien-11beta-yl)-benzoic acid, its derivatives and process for its production
US9517240B2 (en) 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
US20100160275A1 (en) * 2006-09-26 2010-06-24 Lee Eva Y H P Methods and compositions for cancer prevention and treatment
US8299050B2 (en) * 2008-01-29 2012-10-30 Laboratoire Hra-Pharma Method for treating uterine fibroids
US8778969B2 (en) * 2009-11-07 2014-07-15 Peter H Proctor Nitrone, nitroso, and nitroxide spintraps and spin labels and their hydroxylamines
US9096641B2 (en) * 2013-06-05 2015-08-04 Evestra, Inc. Imidazolyl progesterone antagonists

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE289539C (el)
DE287510C (el)
DE290198C (el)
US3187022A (en) * 1964-01-31 1965-06-01 Parke Davis & Co 17beta-amino-17alpha-pregnen-20-one compounds and the production thereof
US4686085A (en) * 1980-04-14 1987-08-11 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
ZA8231B (en) 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2522328B1 (fr) 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
DE3306121A1 (de) * 1983-02-18 1984-09-06 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-spirolaktone in der steroidreihe, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische praeparate
EP0116974B1 (de) * 1983-02-18 1986-10-29 Schering Aktiengesellschaft 11-Beta-Aryl-Estradiene, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE3347126A1 (de) 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
US4481144A (en) 1984-02-03 1984-11-06 E. R. Squibb & Sons, Inc. 17-Substituted thia-17-alkyl(or alkenyl or alkynyl)androstenes
US4529548A (en) 1984-05-07 1985-07-16 E. R. Squibb & Sons, Inc. 17β-(substituted thio)androstenes
NZ214998A (en) 1985-02-07 1989-06-28 Schering Ag 13-(methyl or ethyl)-11-beta-phenyl-gonane derivatives; preparatory processes and pharmaceutical compositions
DE3506785A1 (de) 1985-02-22 1986-08-28 Schering AG, Berlin und Bergkamen, 1000 Berlin 11ss-n,n-dimethylaminophenyl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
FR2596395B1 (fr) 1986-03-26 1989-05-26 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
FR2598421B1 (fr) 1986-05-06 1988-08-19 Roussel Uclaf Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
DE3625315A1 (de) 1986-07-25 1988-01-28 Schering Ag 11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate
US4861763A (en) 1986-09-17 1989-08-29 Research Triangle Institute 17 α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and their progestational use
US4774236A (en) 1986-09-17 1988-09-27 Research Triangle Institute 17α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and pharmaceutical compositions containing them
DE3702383A1 (de) 1987-01-23 1988-08-04 Schering Ag 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
IE60780B1 (en) 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
FR2610933B1 (fr) 1987-02-18 1989-06-09 Roussel Uclaf Nouveaux 19-nor steroides substitues en position 7, leur preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant
ATE69820T1 (de) 1987-04-24 1991-12-15 Akzo Nv 11-arylestranderivate und 11-arylpregnanderivate.
FR2618783B1 (fr) 1987-07-30 1991-02-01 Roussel Uclaf Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
DE3878198T2 (de) 1987-12-12 1993-06-24 Akzo Nv 11-arylsteroid-derivate.
US4954490A (en) * 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
DE3822770A1 (de) 1988-07-01 1990-01-04 Schering Ag 13-alkyl-11ss-phenylgonane
FR2643638B1 (fr) 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
ATE137074T1 (de) 1989-06-20 1996-05-15 Philips Electronics Nv Signalverarbeitungseinrichtungen vor und nach übertragung und/oder speicherung mit datenflussverminderung, und verfahren zur übertragung und/oder speicherung von signalen mit solchen einrichtungen
DE3921059A1 (de) 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
ATE172469T1 (de) 1989-08-04 1998-11-15 Schering Ag 11 beta-aryl-gona-4,9-dien-3-one
DE4042005A1 (de) 1990-12-22 1992-06-25 Schering Ag D-homo-(16-en)-11(beta)-aryl-4-estrene
ZA929315B (en) 1991-12-20 1993-05-24 Akzo Nv 17-spirofuran-3'-ylidene steroids.
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
WO1993021926A1 (en) 1992-05-06 1993-11-11 Medical College Of Hampton Roads Minimizing progestin associated breakthrough bleeding
US5929262A (en) 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
CA2253673C (en) 1996-05-01 2009-09-08 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services 21-substituted progesterone derivatives as new antiprogestational agents
US6020328A (en) 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6172052B1 (en) 1998-12-04 2001-01-09 Research Triangle Institute 17β-acyl-17α-propynyl-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6043235A (en) 1999-07-21 2000-03-28 Research Triangle Institute 11β-aryl-17, 17-spirothiolane-substituted steroids

Also Published As

Publication number Publication date
KR100611289B1 (ko) 2006-08-10
PL344413A1 (en) 2001-11-05
SK285748B6 (sk) 2007-07-06
IL139861A0 (en) 2002-02-10
CA2333669A1 (en) 1999-12-09
HK1035196A1 (en) 2001-11-16
KR20010052427A (ko) 2001-06-25
JP4545929B2 (ja) 2010-09-15
JP2002531381A (ja) 2002-09-24
PT1082337E (pt) 2006-11-30
HU228770B1 (en) 2013-05-28
EP1082337A1 (en) 2001-03-14
ES2270596T3 (es) 2007-04-01
NZ507985A (en) 2003-11-28
SK18092000A3 (sk) 2001-04-09
EP1082337B1 (en) 2006-07-19
NO20005989L (no) 2000-11-27
RU2238943C2 (ru) 2004-10-27
NO317988B1 (no) 2005-01-17
HUP0103109A2 (hu) 2002-01-28
EP1082337A4 (en) 2004-12-29
DK1082337T3 (da) 2006-12-04
NO20005989D0 (no) 2000-11-27
CZ20004446A3 (cs) 2001-04-11
US7018991B2 (en) 2006-03-28
CN1303391A (zh) 2001-07-11
ATE333462T1 (de) 2006-08-15
CA2333669C (en) 2008-08-26
PL198055B1 (pl) 2008-05-30
ID26885A (id) 2001-02-15
HUP0103109A3 (en) 2002-09-30
DE69932432D1 (de) 2006-08-31
WO1999062928A1 (en) 1999-12-09
AU4076199A (en) 1999-12-20
DE69932432T8 (de) 2007-08-23
US20020065257A1 (en) 2002-05-30
CZ300313B6 (cs) 2009-04-15
IL139861A (en) 2005-09-25
DE69932432T2 (de) 2007-03-15
AU753382B2 (en) 2002-10-17
US20040023936A1 (en) 2004-02-05
US6262042B1 (en) 2001-07-17
BR9910794A (pt) 2001-02-13
CN100357311C (zh) 2007-12-26
US6620801B2 (en) 2003-09-16

Similar Documents

Publication Publication Date Title
CY1106443T1 (el) 17β-αμινο και υδροξυλαμινο -11β- αρυλστepοειδη και παραγωγα αυτων που εχουν αγωνιστη ή ανταγωνιστη ορμονικες ιδιοτητες
CY1106444T1 (el) 17b-νιτρο-11β-αρυλοστepοειδη και παραγωγα αυτων ως ορμονικοι αγωνιστες ή ανταγωνιστες
CY1105758T1 (el) Τροποποιημενη απιμιναση αργινινης
CY1111317T1 (el) Παραγωγα 4-φαινυλοπυριδινης και χρηση αυτων ως ανταγωνιστων υποδοχεων της νκ-1
MXPA00008738A (es) 20-ceto-1 1b-arilesteroides y sus derivados teniendo propiedades agonistas o antagonistas hormonales.
CY1106156T1 (el) Νεα χρηση βουδεσονιδης και φορμοτepολης
ATE446955T1 (de) Chinazolinone derivate
CY1109451T1 (el) 17βητα-ακυλ-17αλφα-προπυνυλ-11βητα-(κυκλικα αμινο)αρυλ στεροειδη και παραγωγα αυτων που εχουν ιδιοτητες ορμονικου ανταγωνιστη
CY1116988T1 (el) Βητα-l-2'-δεοξυ-νουκλεοζιτες για την θεραπεια ηπατιτιδας β
CY1106870T1 (el) Σταθεροποιηση ραπαμυκινης ή παραγωγων ραπαμυκινης
SV1997000079A (es) Dihidrato d de olancepina ref. x- 11062t
DE60010098D1 (de) 28-epirapaloge
MXPA03001495A (es) Derivados de fenilalanina novedosos.
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
DE69728585D1 (de) Mittel gegen Juckreiz
CY1109693T1 (el) ΥΠΟΚΑΤΕΣΤΗΜΕΝΑ ΙΜΙΔΑΖΟΛΙΑ ΩΣ ΑΝΑΣΤΟΛΕΙΣ TAFIa
HN1996000017A (es) Isotiazolonas
CY1105078T1 (el) Ανταγωνιστες τεκ
ATE231872T1 (de) Thiazolopyrimidinderivate
TR199802240T2 (el)
ATE309225T1 (de) Substituierte chinazoline derivate
DK1040119T3 (da) Hemiasterlinanaloger
DK0876346T3 (da) Antimalariaaktive quinolinderivater
BR9901392A (pt) Hidroxi-metil-hexanonas como agentes aromatizantes.
SE9801494D0 (sv) Novel use